Timing of Tracheostomy in COVID-19 - Impact on Mortality

Goethe University117 enrolled

Overview

How timing of tracheostomy in COVID-19 patients changed and its impact on mortality in patients with severe COVID-19 ARDS

Study Type

OBSERVATIONAL

Enrollment

117

Conditions

Tracheostomy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Severe COVID-19 infection requiring endotracheal intubation and prolonged invasive ventilation as part of the treatment of severe to moderate acute respiratory distress syndrome. Exclusion Criteria: * COVID-19 disease, without the need for endotracheal ventilation. * COVID-19 disease with need for endotracheal intubation with anticipated short-term invasive ventilation.

Locations (1)

University Hospital Frankfurt

Niederrad, Hesse, Germany

Outcomes

Primary Outcomes

Mortality

Deaths in the course of treatment

Time frame: During intensive care treatment (Usually within 8 weeks)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.